相关实验视频

Updated: Jun 20, 2025

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

LRRK2激酶活性限制了微质中的NRF2依赖性线粒体保护

Chi G Weindel¹, Lily M Ellzey¹, Aja K Coleman¹

¹Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Texas A&M School of Medicine, TX, 77807, USA.

bioRxiv : the preprint server for biology

|July 19, 2024

概括

氨酸丰富的重复激酶2 (LRRK2) 的损失矛盾地通过降低I型干扰素信号传递来减少微质中的神经炎症,与其对外围巨细胞的影响不同. 这保护了微质线粒体,提高了新陈代谢.

科学领域:

神经免疫学神经免疫学
细胞和分子神经科学

背景情况:

中枢神经系统 (CNS) 的质细胞与神经炎症和神经退行性疾病有关.
在外围巨细胞中失去与帕金森病相关的LRRK2基因会增加I型干扰素信号传递.
这种增加与线粒体压力和通过cGAS/STING通路感应DNA有关.

研究的目的:

研究LRRK2在微质细胞,即中枢神经系统特异性免疫细胞中的作用.
了解LRRK2在不同类型的免疫细胞中丧失的矛盾效应.
探索LRRK2对I型干扰素信号传递和微质中的线粒体功能的影响.

主要方法:

使用了原始的小鼠微质细胞和微质细胞系.
对于LRRK2,使用了功能丧失 (KO) 模型.
对I型干扰素刺激基因 (ISG),线粒体压力,新陈代谢和NRF2活性进行了分析.

主要成果:

矛盾的是,微质中LRRK2的损失降低了I型干扰素信号发送和ISG表达的强度.
缺乏LRRK2可以保护微质线粒体免受压力,并增强其新陈代谢.
这些效应与NRF2上调相关,并取决于LRRK2激酶活性.

结论:

在中枢神经系统和外围之间,LRRK2在免疫调节中表现出二分之一的作用.
微质LRRK2损失赋予了一个保护性表型,与外围巨细胞形成鲜明对比.
这些发现提供了关于中枢神经系统和外围的免疫差异以及神经炎症的调节的见解.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

相关概念视频

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...